Thursday, July 26, 2018, 12-1 PM EDT

Iron Deficiency Anemia and Heavy Menstrual Bleeding: Prevalence, Impact, Management

REGISTER HERE

Program Description

This state-of-the-science Webinar will detail and disseminate current best practices in the treatment and management of iron deficiency anemia (IDA) and heavy menstrual bleeding. This Webinar will have a special focus on the epidemiology, impact, and management of IDA on women, especially those women with a blood disorder. 

Learning Objectives:

  • Cite the prevalence of iron deficiency anemia in females of childbearing age and with heavy menstrual bleeding as reported in national surveys, multicenter and single center study reports
  • Recognize the breadth of health impact caused by iron deficiency and anemia in females with heavy menstrual bleeding
  • Discuss the impact on healthcare utilization due to iron deficiency anemia in females with heavy menstrual bleeding
  • Recognize and manage the range of medical complications due to iron deficiency anemia in females with heavy menstrual bleeding
  • Describe and appropriately apply available new and state-of-the-science therapeutics/treatments in the optimal management of women with iron deficiency anemia and heavy menstrual bleeding
  • Evaluate available iron replacement therapies – including appropriate dosing strategies and adverse effects of oral and intravenous iron
  • Manage the hematologic and patient-reported outcomes associated with iron replacement therapy in women 

Faculty:

Lakshmi Srivaths, M.D.

Lakshmi Srivaths, MD, is a Professor in the Department of Pediatrics, Section of Hematology-Oncology at the Baylor College of Medicine, Houston, Texas. She is the Co-Director of the Young Women’s Bleeding Disorder Clinic and a member of the General Hematology Program, and Hemostasis and Thrombosis Program. She is the recipient of the Fulbright & Jaworski L. L. P. Faculty Excellence Award, 2011 and 2016 in the “Teaching and Evaluation” category, Rising Star Clinician Award, Baylor College of Medicine, 2015 and the Fellow’s Education Award, Texas Children’s Cancer and Hematology Center, 2011. Dr. Srivaths is a member of the Foundation for Women & Girls with Bleeding Disorders Medical Advisory Council, an inaugural member of the FWGBD Education Council, and an active participant in the WGBD Learning Action Network (LAN).

Jacquelyn Powers, M.D., MSc

Jacquelyn Powers, MD, MSc, is currently an Assistant Professor of Pediatrics at Baylor and Texas Children’s Cancer Center. She was appointed as the American Academy of Pediatrics and American Society of Pediatric Hematology/Oncology representative on the AABB Committee on Donor Iron Safety and Health, a national committee that is developing recommendations on iron replacement in blood donors to prevent the development of iron deficiency, maintain the blood donor pool and ensure the maintenance of an adequate and safe blood supply.

Credit Statements

Category 1 - Creighton University Health Sciences Continuing Education designates this Live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM.  Physicians should claim only credit commensurate with the extent of their participation in the activity.

AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.

Nurse CE - Creighton University Health Sciences Continuing Education designates this activity for 1.0 contact hours for nurses.  Nurses should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education and The Foundation for Women & Girls with Blood Disorders.  Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.